Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers

A Phase I Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-04802540 After Multiple Oral Dose Administration To Healthy Adult Volunteers

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of multiple ascending doses of PF-04802540 administered orally to healthy adult subjects.

Evaluation of safety and pharmacokinetics

Inclusion Criteria:

• Males or females of non-childbearing capacity aged 21 to 55 years inclusive at screening.
• Body mass index in the range of 18 to 30 kg/m2 and body weight>45 kg.
• Healthy as determined by the investigator on the basis of screening evaluation.

Exclusion Criteria:

• Use of prescription or nonprescription drugs
• Any condition possibly affecting drug absorption